Symposium 2012: Friday Schedule


Friday Schedule Friday Saturday

Accelerating the Cure Through Clinical Research
1:00-5:00 pm, November 30, 2012

Lunch and Registration: 12:00 - 1:00 pm
Program: 1:00 - 5:00 pm
Please join us for a reception following the program.

Georgetown University Hotel & Conference Center
3800 Reservoir Road, NW, Washington, DC 20007

12:00-1:00 pm
Lunch and registration


1:00 pm

John L. Marshall, MD
Director, Ruesch Center for the Cure of Gastrointestinal Cancers
Chief, Division of Hematology/Oncology, Georgetown Lombardi Comprehensive Cancer Center

1:15-2:00 pm

The State of Cancer Clinical Research in the US and the World: Progress at the 3% Accrual Rate
Moderator: Margo Michaels
Executive Director and President, Education Network to Advance Cancer Clinical Trials

The Role of Government in Clinical Research: Restructuring the NCI's Clinical Trials Program
James Zwiebel, MD
Chief, Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute

The Projected Impact of a 20% Accrual Rate on the Cost of Drug Development
Todd Shuster, MD
Senior Director, Clinical Development, and Oncology Therapeutic Area Co-Leader, PAREXEL International

Accrual in the Community, and the Impact of Sudden Success
Lori Minasian, MD, FACP
Deputy Director, Division of Cancer Prevention, National Cancer Institute

Question and Answer Session

2:00-3:15 pm

Going from 3% to 20%+: The Potential Impact on the Race
Introduction: John L. Marshall, MD

Schafer Memorial Lecture
Deborah Schrag, MD, MPH
Associate Professor, Department of Medicine, Harvard Medical School, Adult Oncology, Dana-Farber Cancer Institute

The Thomas R. Schafer Memorial Lecture Fund for Research and Education in Pancreatic and Gastrointestinal Cancer was established in 1999 as a tribute by the late Thomas Schafer's family and friends. They felt strongly that his spirit should live on through this fund for an annual lectureship, designed to discuss the latest concepts and innovations in cancer therapy.

Panel Discussion

Moderator: Brian Rye
Health Care Financial Analyst for Bloomberg Government

Alan Wertheimer, PhD
Senior Research Scholar, Department of Bioethics, National Institutes of Health

Carol Palackdharry, MD, MS
Medical Director, ActiveHealth Management; Clinical Lead, Oncology Condition Analysis, Aetna

Louis Jacques, MD
Director, Coverage & Analysis Group, Office of Clinical Standards and Quality, Centers for Medicare and Medicaid Services

3:15-3:45 pm - Break

3:45-5:00 pm

Engaging the Other 97%: Why Aren't Cancer Patients Up in Arms?

Moderator: Amanda Bennett
Author, "The Cost of Hope: A Memoir"
Executive Editor, Bloomberg News


  • Ruesch Board Members
  • Patients and Family Members
  • David L. Evans, MD

Senior Vice President, Clinical Programs, ActiveHealth Management

  • Howard Fingert, MD, FACP

Senior Medical Director, Millennium, the Takeda Oncology Company

  • Ruesch Center Faculty

5:00-7:00 pm - Reception